Cargando…
Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
OBJECTIVE—The purpose of this study was to investigate whether genetic variants could influence the antidiabetic efficacy of gliclazide in type 2 diabetic patients. RESEARCH DESIGN AND METHODS—A total of 1,268 type 2 diabetic patients whose diabetes was diagnosed within the past 5 years and who had...
Autores principales: | Feng, Yan, Mao, Guangyun, Ren, Xiaowei, Xing, Houxun, Tang, Genfu, Li, Qiang, Li, Xueqi, Sun, Lirong, Yang, Jinqui, Ma, Weiqing, Wang, Xiaobin, Xu, Xiping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551631/ https://www.ncbi.nlm.nih.gov/pubmed/18599530 http://dx.doi.org/10.2337/dc07-2248 |
Ejemplares similares
-
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis
por: Bodmer, Michael, et al.
Publicado: (2008) -
Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K(+) Channel
por: Hamming, Kevin S.C., et al.
Publicado: (2009) -
Bioavailability and Antidiabetic Activity of Gliclazide-Loaded Cubosomal Nanoparticles
por: Nasr, Mohamed, et al.
Publicado: (2021) -
The ATP-Sensitive K(+) Channel ABCC8 S1369A Type 2 Diabetes Risk Variant Increases MgATPase Activity
por: Fatehi, Mohammad, et al.
Publicado: (2012) -
1369. The Spectrum of Chronic Osteomyelitis in Children
por: Joseph, Marritta, et al.
Publicado: (2020)